Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease
- PMID: 15680062
- DOI: 10.1017/S1047951104244225
Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease
Erratum in
- Cardiol Young. 2004 Oct;14(5):579
Comment on
-
Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.Cardiol Young. 2003 Oct;13(5):420-3. Cardiol Young. 2003. PMID: 14694935
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
